4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-007669
Chief Financial Officer sold 3,326 shares at $11.11 ($36,954)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2026-01-06 | Sale | −3,326 | $11.11 | $36,954 | 177,104 | D: show line 1 in the form |
| Open-market sales · 3,326 sh · avg $11.11 · $36,954 | |||||||
Loading xslF345X05/ownership.xml…